CoChat

Anti‐tumor activity of mesenchymal stem cells producing IL‐12 in a mouse melanoma model

Elzaouk, Lina, Moelling, Karin, Pavlovic, Jovan · 2006 · Experimental Dermatology
Cited by 128

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Mesenchymal stem cells (MSCs) represent a new tool for delivery of therapeutic agents to tumor cells. In this study, we have evaluated the anti‐tumor activity of human MSCs stably transduced with a retroviral vector expressing the cytokine interleukin‐12 (IL‐12) in a mouse melanoma model. Application of MSC(IL‐12) but not control MSCs strongly reduced the formation of lung metastases of B16F10 melanoma cells. The activity of the MSC(IL‐12) cells was dependent on the presence of natural killer (NK) cells in this experimental setting. Further, MSC(IL‐12) cells elicited a pronounced retardation of tumor growth and led to prolonged survival when injected into established subcutaneous melanoma in a therapeutic regimen. The therapeutic effect of the MSC(IL‐12) was in part mediated by CD8+ T cells, while NK cells and CD4+ T cells appeared to play a minor role. The anti‐tumor effect of MSC(IL‐12) cells was of similar efficiency as observed for application of naked plasmid DNA encoding IL‐12. The presented data demonstrate that these two different strategies can induce a similar therapeutic anti‐tumor efficacy in the mouse melanoma tumor model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0625.2006.00479.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 128

Metadata

Authors
Elzaouk, L., Moelling, K., & Pavlovic, J.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2006-09-26
Volume
15
Issue
11
Pages
865-874
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W2020794309
Cited by
128
References
2
FWCI
5.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.